Skip to main content

Rivastigmine Tartrate

NDC 71209-012 · Cadila Pharmaceuticals Limited

Generic nameRivastigmine Tartrate

Dosage formCAPSULE

RouteORAL

Active ingredient(s)RIVASTIGMINE TARTRATE

Strength1.5 mg/1

Pharmacologic classCholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]

Marketing categoryANDA

Packages

71209-012-03 — 60 CAPSULE in 1 BOTTLE (71209-012-03)

71209-012-10 — 500 CAPSULE in 1 BOTTLE (71209-012-10)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

62332-065 — Rivastigmine Tartrate, 62332-066 — Rivastigmine Tartrate, 62756-145 — Rivastigmine Tartrate, 62756-146 — Rivastigmine Tartrate, 62756-147 — Rivastigmine Tartrate, 62756-148 — Rivastigmine Tartrate, 65862-648 — Rivastigmine Tartrate, 65862-649 — Rivastigmine Tartrate, 65862-650 — Rivastigmine Tartrate, 65862-651 — Rivastigmine Tartrate, 71209-013 — Rivastigmine Tartrate, 71209-014 — Rivastigmine Tartrate, 71209-015 — Rivastigmine Tartrate, 72241-011 — Rivastigmine Tartrate, 72241-012 — Rivastigmine Tartrate, 72241-013 — Rivastigmine Tartrate, 72241-014 — Rivastigmine Tartrate, 75834-133 — RIVASTIGMINE TARTRATE, 75834-134 — RIVASTIGMINE TARTRATE, 75834-135 — RIVASTIGMINE TARTRATE, +21 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.